Clinical Trials Directory

Trials / Completed

CompletedNCT01892657

Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test

Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Semi-occlusive Patch)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study examined the possible sensitization and irritation effects of a moisturizer with sunscreen SPF 50+.

Detailed description

The design for this study is standard for human repeat insult patch tests. To test the moisturizer with sunscreen SPF 50+ for the potential to induce contact sensitization by repetitive applications, healthy subjects received 9 applications at 48 to 72 hour intervals of the moisturizer to the upper back. Patches were remained on the skin for approximately 48 to 72 hours. Twelve to 24 days after the previous applications, subjects were patched with the moisturizer at the original site and an alternative site for 48 hours.

Conditions

Interventions

TypeNameDescription
DRUGFacial Moisturizer with SPF 50+All subjects received applications of occlusive patches dosed with Cetaphil Daily Facial Moisturizer with SPF 50+

Timeline

Start date
2008-03-01
Primary completion
2008-05-01
Completion
2008-08-01
First posted
2013-07-04
Last updated
2022-08-01
Results posted
2013-09-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01892657. Inclusion in this directory is not an endorsement.